05-23-0600 Sigma-AldrichSubstance P - CAS 33507-63-0 - Calbiochem
Neuropeptide found in high concentrations in the gut.
More>> Neuropeptide found in high concentrations in the gut. Less<<Sinónimos: RPKPQQFFGLM
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
33507-63-0 | C₆₃H₉₈N₁₈O₁₃S |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
05-23-0600-1MG |
|
Ampolla de plást. | 1 mg |
|
— | |
05-23-0600-25MG |
|
Ampolla de plást. | 25 mg |
|
— | |
05-23-0600-5MG |
|
Ampolla de plást. | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 33507-63-0 |
ATP Competitive | N |
Form | White solid |
Formulation | Supplied as a trifluoroacetate salt. |
Hill Formula | C₆₃H₉₈N₁₈O₁₃S |
Chemical formula | C₆₃H₉₈N₁₈O₁₃S |
Hygroscopic | Hygroscopic |
Reversible | N |
Sold on the basis of peptide content | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Substance P receptors |
Purity | ≥96% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Peptide Content | Y |
Peptide Sequence | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH₂ |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
05-23-0600-1MG | 04055977207019 |
05-23-0600-25MG | 04055977207026 |
05-23-0600-5MG | 04055977207033 |
Documentation
Substance P - CAS 33507-63-0 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Substance P - CAS 33507-63-0 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
05-23-0600 |
Referencias bibliográficas
Visión general referencias |
---|
Roush, E.D., and Kwatra, M.M. 1998. FEBS Lett. 428, 291. Chiwakata, C.B., et al. 1996. Infect. Immun. 64, 5106. Tanabe, T., et al. 1996. Eur. J. Pharmacol. 299, 187. Heath, M.J., et al. 1994. J. Neurophysiol. 72, 1192. Zhu, J., et al. 1994. Eur. J. Pharmacol. 268, 279. Garland, A.M., et al. 1993. Soc. Neurosci. 19, Abstract 104.6. Wei, J.Y., et al. 1993. Soc. Neurosci. 19, Abstract 136.14. |